The impact of COVID-19 on women’s reproductive system.

Publication date: Sep 11, 2024

The coronavirus disease 2019 (COVID-19) pandemic has been a major global focus since 2019. However, drug development and vaccination have been unable to stop the rise in the number of COVID-19 infections. As a result, almost everyone has been infected with COVID-19. As the COVID-19 pandemic nears its end, it is important to explore whether contracting COVID-19 has any irreversible effects on the female reproductive system. This article aims to review the effects of COVID-19 on the female ovary and reproductive system and examine whether these effects are permanent. In conclusion, we can state that COVID-19 has not caused any long-lasting effects on the reproductive health of most women, with the exception of a few cases where premature ovarian failure has been observed. These temporary effects, such as menstrual disturbances and temporary fertility loss, tend to diminish and eventually disappear over time.

Open Access PDF

Concepts Keywords
Coronavirus COVID-19
Covid menstruation
Menstrual ovary
Pandemic pregnant women
Women reproductive system

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infections
disease MESH premature ovarian failure
disease IDO infectivity
disease IDO infection
drug DRUGBANK Coenzyme M
pathway REACTOME Reproduction
disease MESH premature ovarian failure 5
disease MESH coronavirus infection
disease MESH inflammation
disease MESH psychological stress
disease MESH anxiety
disease MESH viral infection
disease MESH complications
disease MESH fetal growth restriction
disease MESH menstrual irregularities
disease MESH infertility
disease MESH fetal distress
pathway REACTOME Immune System
disease MESH morbidity
disease MESH cytokine storm syndrome
disease MESH infectious diseases
drug DRUGBANK Estradiol
disease MESH death
disease MESH low birth weight

Original Article

(Visited 3 times, 1 visits today)